REGENERON COMPLETES 12-MONTH EFFICACY PHASE OF AXOKINE(R) PHASE III PIVOTAL TRIAL FOR THE TREATMENT OF OBESITY

Tuesday, January 21, 2003 1 min read

Key Takeaway: REGENERON COMPLETES 12-MONTH EFFICACY PHASE OF AXOKINE(R) PHASE III PIVOTAL TRIAL FOR THE TREATMENT OF OBESITY

Full Press Release Details

REGENERON COMPLETES 12-MONTH EFFICACY PHASE OF AXOKINE(R) PHASE III PIVOTAL TRIAL FOR THE TREATMENT OF OBESITY.